[Antibiotic lincomycin].
D000818:Animals; D001419:Bacteria / Q000187:drug effects; D001646:Bile / Q000032:analysis; D002648:Child; D004285:Dogs; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007239:Infections / Q000188:drug therapy; D007422:Intestines / Q000032:analysis; D008034:Lincomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis / Q000037:antagonists & inhibitors / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology* / Q000627:therapeutic use* / Q000633:toxicity / Q000652:urine; D008581:Meningitis / Q000134:cerebrospinal fluid; D051379:Mice; D051381:Rats; D013203:Staphylococcal Infections / Q000188:drug therapy; D013752:Tetracycline / Q000494:pharmacology
D004917:Erythromycin; D008034:Lincomycin; D013752:Tetracycline
Antibiotik linkomitsin.